Lucie Ailhaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lucie Ailhaud has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Philippe Parola
IHU-Méditerranée Infection, Marseille, France; Aix-Marseille Univ, IRD, APHM, VITROME, Marseille, France
3 shared publicationsBarbara Doudier
IHU-Méditerranée Infection, Marseille, France
2 shared publications- Bernard La Scola
Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université
2 shared publications Camille Aubry
IHU-Méditerranée Infection, Marseille, France; Aix-Marseille Univ, IRD, APHM, MEPHI, Marseille, France
2 shared publicationsDidier Raoult
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
2 shared publicationsPhilippe Brouqui
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
2 shared publications
Latest Publications
- Open Access
- 17 April 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (4) , 86
Impact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis
Background: Infective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically. Objectives: The objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE. Methods: We conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups. Results: A total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (p = 0.009). There was no significant difference in surgery including intra-cardiac device extraction (p = 0.412) or time to surgery (p = 0.894). The one-year mortality was similar in both groups (16% versus 17.7%, p = 0.704). The recurrence rate was not significantly different between the two groups (5.9% in Group 2 versus 9.1% in Group 1, p = 0.311). Conclusions: The SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.
- 17 April 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (4) , 86
Open AccessImpact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis
Background: Infective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically. Objectives: The objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE. Methods: We conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups. Results: A total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (p = 0.009). There was no significant difference in surgery including intra-cardiac device extraction (p = 0.412) or time to surgery (p = 0.894). The one-year mortality was similar in both groups (16% versus 17.7%, p = 0.704). The recurrence rate was not significantly different between the two groups (5.9% in Group 2 versus 9.1% in Group 1, p = 0.311). Conclusions: The SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.
- 1 September 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 37, 101866
Neurocysticercosis, re-infection or inflammation?
- 1 September 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 37, 101866
Neurocysticercosis, re-infection or inflammation?
- 1 July 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 36, 101632
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
- 1 July 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 36, 101632
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
- 1 March 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 34, 101624
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
- 1 March 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 34, 101624
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?